BYRN vs RCAT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 29, 2026

BYRN

39.6
AI Score
VS
RCAT Wins

RCAT

57.8
AI Score

Investment Advisor Scores

BYRN

40score
Recommendation
AVOID NEW MONEY

RCAT

58score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BYRN RCAT Winner
Forward P/E 22.7273 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -42.5% 527.2% RCAT
Earnings Growth -57.1% 0.0% RCAT
Tradestie Score 39.6/100 57.8/100 RCAT
Profit Margin -3.4% -136.3% BYRN
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD RCAT

Relative Price Performance (Last 90 Days)

BYRN 1M: +6.5% · 3M: -41.0% RCAT 1M: -25.7% · 3M: -31.3%

Current Technical Phase

BYRN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.8 · Price: $3.63

RCAT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.1%), weak momentum, RSI 31

RSI (14): 31.1 · Price: $6.35

Fundamentals Snapshot

Metric BYRN RCAT
Market Cap — —
Forward P/E -16.5 -21.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.4% 5.3%
Gross Margin 0.5% 0.1%
Operating Margin -0.8% -1.9%
EPS -0.18 -0.80
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.